CAPROCK Group, Inc.

SEC CIK: 0001610769
Latest filing: Jul 27, 2026

SEC filings (opens in a new tab)

ALNY holding history

Alnylam Pharmaceuticals, Inc. in every 13F filed by CAPROCK Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALNY overview All 13F holders of ALNY Full Q2 2026 holdings

Shares (Q2 2026): 0; Sold out in Q2 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q3 2025

Holdings of ALNY by CAPROCK Group, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	0	$0	0.0%	−1,190−100.0%	Sold out	Holders
Q1 2026	1,190	$393.8K	<0.1%	+198+20.0%	Added	Holders
Q4 2025	992	$394.5K	<0.1%	+135+15.8%	Added	Holders
Q3 2025	857	$382.7K	<0.1%	–	No prior filing	Holders